Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates
November 08, 2024 16:23 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene autoleucel – obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obe-cel) for adults with relapsed/refractory B-cell acute lymphoblastic leukemia
November 05, 2024 09:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 in One Oral Presentation and Three Poster Presentations

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
October 28, 2024 17:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
October 16, 2024 09:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress

Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress
September 19, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer
August 27, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Presents Clinical Data Update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024

Autolus presents clinical data update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024
August 08, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
July 26, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
June 14, 2024 07:00 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress

Autolus Therapeutics to Present Three Clinical Data Updates on obe-cel at EHA

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right